Literature DB >> 27118572

Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.

Filip Pirsl1, Lauren M Curtis2, Seth M Steinberg3, Sri Harsha Tella4, Mašenjka Katić1, Marnie Dobbin5, Jennifer Hsu1, Fran T Hakim1, Jacqueline W Mays6, Annie P Im7, Dražen Pulanić8, Sandra A Mitchell9, Judy Baruffaldi1, Licia Masuch1, David C Halverson1, Ronald E Gress1, Julianna Barsony10, Steven Z Pavletic1.   

Abstract

The National Institutes of Health Chronic Graft-versus-Host Disease (cGVHD) Consensus Project Ancillary and Supportive Care Guidelines recommend annual assessment of bone mineral density (BMD) to monitor bone health. The study of osteoporosis in patients with cGVHD has been limited to small numbers of patients, and the guidelines are based on experience with other chronic diseases and expert opinion. We hypothesized that the prevalence of osteoporosis is high in a cohort of 258 patients with moderate to severe cGVHD because of prolonged exposure to risk factors for osteoporosis after allogeneic hematopoietic stem cell transplantation. We defined osteoporosis using BMD criteria (T-score ≤-2.5) at 3 anatomic sites-the femoral neck (FN), lumbar spine (LS), and total hip (TH)-and characterized risk factors through univariate and multivariate analyses. We found that low body weight (FN, P < .0001; LS, P = .0002; TH, P < .0001), malnutrition (FN, P = .0002; LS, P = .03; TH, P = .0076), higher platelet count (FN, P = .0065; TH, P = .0025), higher average National Institutes of Health organ score (FN, P = .038), higher prednisone dose (LS, P = .032), lower complement component 3 (LS, P = .0073), and physical inactivity (FN, P = .01) were associated with osteoporosis in at least 1 site. T-scores were significantly lower in the FN compared with the LS or TH (P < .0001 for both). The prevalence of osteoporosis and osteopenia was high (17% and 60%, respectively), supporting current recommendations for frequent monitoring of BMD. The association of higher platelet count in patients with cGVHD and osteoporosis has not been reported previously and represents a new area of interest in the study of osteoporosis after allogeneic hematopoietic stem cell transplantation. Published by Elsevier Inc.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Chronic graft-versus-host disease; Late effects; Osteoporosis; Platelets; Supportive care

Mesh:

Year:  2016        PMID: 27118572      PMCID: PMC4949073          DOI: 10.1016/j.bbmt.2016.04.012

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  49 in total

1.  Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.

Authors:  T Bat; S M Steinberg; R Childs; K R Calvo; A J Barrett; M Battiwalla; K Baird; D Zhang; D Pulanic; C E Dunbar; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2013-07-08       Impact factor: 5.483

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

Review 3.  Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options.

Authors:  C Early; L Stuckey; S Tischer
Journal:  Osteoporos Int       Date:  2015-10-16       Impact factor: 4.507

Review 4.  The pathophysiology and clinical relevance of platelet heterogeneity.

Authors:  C B Thompson; J A Jakubowski
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

5.  Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.

Authors:  Steven Z Pavletic; Lynette M Smith; Michael R Bishop; James C Lynch; Stefano R Tarantolo; Julie M Vose; Philip J Bierman; Abdul Hadi; James O Armitage; Anne Kessinger
Journal:  Am J Hematol       Date:  2005-04       Impact factor: 10.047

6.  Mean platelet volume is negatively associated with bone mineral density in postmenopausal women.

Authors:  Xue-song Li; Ji-rong Zhang; Song-yan Meng; Ying Li; Rui-tao Wang
Journal:  J Bone Miner Metab       Date:  2012-06-09       Impact factor: 2.626

7.  Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility.

Authors:  Emmanuelle Assouline; Roberto Crocchiolo; Thomas Prebet; Florence Broussais; Diane Coso; Marc Gamerre; Norbert Vey; Didier Blaise; Blandine Courbiere
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-09-24

8.  Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation.

Authors:  J-H Lee; S-J Choi; J-H Lee; S-E Kim; M Seol; Y-S Lee; J-S Lee; W-K Kim; K-H Lee
Journal:  Bone Marrow Transplant       Date:  2005-01       Impact factor: 5.483

9.  Increased incidence of fractures in recipients of hematopoietic stem-cell transplantation.

Authors:  Xerxes N Pundole; Andrea G Barbo; Heather Lin; Richard E Champlin; Huifang Lu
Journal:  J Clin Oncol       Date:  2015-03-16       Impact factor: 44.544

10.  The short-term changes of bone mineral metabolism following bone marrow transplantation.

Authors:  M I Kang; W Y Lee; K W Oh; J H Han; K H Song; B Y Cha; K W Lee; H Y Son; S K Kang; C C Kim
Journal:  Bone       Date:  2000-03       Impact factor: 4.398

View more
  4 in total

1.  Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.

Authors:  Nataliya P Buxbaum; Cemre Robinson; Ninet Sinaii; Alexander Ling; Lauren M Curtis; Steven Z Pavletic; Kristin Baird; Maya B Lodish
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-01       Impact factor: 5.742

2.  Effect of Rhizoma Drynariae on differential gene expression in ovariectomized rats with osteoporosis based on transcriptome sequencing.

Authors:  Hui Su; Haipeng Xue; Shang Gao; Binghan Yan; Ruochong Wang; Guoqing Tan; Zhanwang Xu; Lingfeng Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

3.  Allogeneic yet major histocompatibility complex-matched bone marrow transplantation in mice results in an impairment of osteoblasts and a significantly reduced trabecular bone.

Authors:  Anja Osterberg; Robby Engelmann; Brigitte Müller-Hilke
Journal:  J Bone Miner Metab       Date:  2017-08-01       Impact factor: 2.626

Review 4.  Blood factors as biomarkers in osteoporosis: points from the COVID-19 era.

Authors:  Francesca Salamanna; Melania Maglio; Veronica Borsari; Maria Paola Landini; Milena Fini
Journal:  Trends Endocrinol Metab       Date:  2021-07-07       Impact factor: 12.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.